Preventive Care in Nursing and Midwifery Journal
Volume 14, Issue 2 (8-2024)
Prev Care Nurs Midwifery J 2024, 14(2): 1-10 |
Back to browse issues page
Ethics code: IR.ZUMS.REC.1402.020
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Yousefli Z, Aghvamy M S, Ghahramani Z. The relationship between psychological stress and medication regimen adherence in patients with type 2 diabetes. Prev Care Nurs Midwifery J 2024; 14 (2) :1-10
URL: http://nmcjournal.zums.ac.ir/article-1-906-en.html
URL: http://nmcjournal.zums.ac.ir/article-1-906-en.html
Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Zanjan University of Medical Sciences, Zanjan, Iran , aghvamym@zums.ac.ir
Abstract: (1742 Views)
Background: Diabetes is considered one of the most arduous chronic diseases emotionally and behaviorally. This disease is an integral part of the patient’s lives, and not paying attention to the psychological stress stemming from it, not only leads to the occurrence of psychological symptoms and frustration, but also influences self-care behaviors, such as blood sugar control, proper use of medicines, and medication regimen adherence.
Objectives: This study was conducted to determine the relationship between psychological stress and medication regimen adherence in patients with type 2 diabetes.
Methods: This descriptive-correlational study was conducted on 101 patients referring to diabetes clinics affiliated with Zanjan University of Medical Sciences in 2023. Sampling was carried out using the convenience sampling method. A demographic characteristics questionnaire, the Problems Areas in Diabetes-5 (PAID-5) Scale, and the Mo risky Medication Adherence Scale-8 (MMAS-8) were used to collect data. Data were analyzed using descriptive statistics, the Mann-Whitney U test, the Kruskal-Wallis test, and Spearman’s test, with SPSS-26 software.
Results: In the present research, 68.3% of the participants were female and 31.7% were male. The mean (standard deviation) stress score was 9.579 (7.448). Also, 58.4% of the participants had a stress score of ≥8, indicating high psychological stress. The mean (standard deviation) of medication adherence was 6.054 (1.874), which based on the findings, 43.6% had a poor adherence score. Spearman’s correlation coefficient showed an inverse and significant statistical relationship between psychological stress and medication adherence (p =0.002, r=-0.307).
Conclusion: According to the results, the higher the psychological stress of diabetic patients, the lower their medication adherence. It is suggested that targeted interventions should be designed to manage psychological stress and improve medication adherence in diabetic patients.
Objectives: This study was conducted to determine the relationship between psychological stress and medication regimen adherence in patients with type 2 diabetes.
Methods: This descriptive-correlational study was conducted on 101 patients referring to diabetes clinics affiliated with Zanjan University of Medical Sciences in 2023. Sampling was carried out using the convenience sampling method. A demographic characteristics questionnaire, the Problems Areas in Diabetes-5 (PAID-5) Scale, and the Mo risky Medication Adherence Scale-8 (MMAS-8) were used to collect data. Data were analyzed using descriptive statistics, the Mann-Whitney U test, the Kruskal-Wallis test, and Spearman’s test, with SPSS-26 software.
Results: In the present research, 68.3% of the participants were female and 31.7% were male. The mean (standard deviation) stress score was 9.579 (7.448). Also, 58.4% of the participants had a stress score of ≥8, indicating high psychological stress. The mean (standard deviation) of medication adherence was 6.054 (1.874), which based on the findings, 43.6% had a poor adherence score. Spearman’s correlation coefficient showed an inverse and significant statistical relationship between psychological stress and medication adherence (p =0.002, r=-0.307).
Conclusion: According to the results, the higher the psychological stress of diabetic patients, the lower their medication adherence. It is suggested that targeted interventions should be designed to manage psychological stress and improve medication adherence in diabetic patients.
Type of Study: Orginal research |
Subject:
Nursing
References
1. Alzahrani A, Alghamdi A, Alqarni T, Alshareef R, Alzahrani A. Prevalence and predictors of depression, anxiety, and stress symptoms among patients with type II diabetes attending primary healthcare centers in the western region of Saudi Arabia: a cross-sectional study. International Journal of Mental Health Systems. 2019;13:48. [https://doi.org/10.1186/s13033-019-0307-6] [PMID] []
2. Khalighi Z, Badfar G, Mahmoudi L, Soleymani A, Azami M, Shohani M. The prevalence of depression and anxiety in Iranian patients with diabetes mellitus: A systematic review and meta-analysis. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2019;13(4):2785-94. [https://doi.org/10.1016/j.dsx.2019.07.004] [PMID]
3. Bullard KM, Cowie CC, Lessem SE, Saydah SH, Menke A, Geiss LS, et al. Prevalence of diagnosed diabetes in adults by diabetes type United States, 2016. Morbidity and Mortality Weekly Report. 2018;67(12):359-61. Available from: https://www.cdc.gov/mmwr/volumes/67/wr/pdfs/mm6712a2-H.pdf [https://doi.org/10.15585/mmwr.mm6712a2] [PMID]
4. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. The Lancet. 2017;389(10085):2239-51. [https://doi.org/10.1016/S0140-6736(17)30058-2] [PMID]
5. Cho NH, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice. 2018;138:271-81. [https://doi.org/10.1016/j.diabres.2018.02.023] [PMID]
6. Rashedi V, Asadi-Lari M, Delbari A, Fadayevatan R, Borhaninejad V, Foroughan M. Prevalence of diabetes type 2 in older adults: Findings from a large population-based survey in Tehran, Iran (Urban HEART-2). Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2017;11 Suppl 1:S347-50. [https://doi.org/10.1016/j.dsx.2017.03.014] [PMID]
7. Asadolahi K, Veisani Y, Momeni K. Investigating the direct and indirect costs of diabetes in Ilam city in 2018. Technology and Research Information System. 2022;5(1):57-68. [http://newresearch.medilam.ac.ir/article-1-670-en.html]
8. Mansuri A, Khammri M, Nooshirvani S, Nooshirvani H. Evaluation of the effect of vitamin C supplements on fasting plasma glucose and glycosylated hemoglobin in patients with type II diabetes. Journal of Diabetes Nursing. 2016;4(3):40-7. [http://jdn.zbmu.ac.ir/article-1-208-en.html]
9. Majlessi F, Mohebbi B, Tol A, Azam K. Assessing the effect of educational intervention on treatment adherence based on AIM model among patients with type 2 diabetes. Iranian Journal of Diabetes and Metabolism. 2017;16(3):173-82. [http://ijdld.tums.ac.ir/article-1-5564-en.html]
10. Paquot N. Deleterious effects of lack of compliance to lifestyle and medication in diabetic patients. Revue Medicale de Liege. 2010;65(5-6):326-31.
11. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17(9):961-9. [https://doi.org/10.2337/diacare.17.9.961] [PMID]
12. Kennedy-Martin T, Boye KS, Peng X. Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review. Patient Preference and Adherence. 2017;11:1103-17. [https://doi.org/10.2147/PPA.S136639] [PMID]
13. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218-24. [https://doi.org/10.2337/diacare.27.5.1218] [PMID]
14. Ghosh A, Gupta R, Misra A. Telemedicine for diabetes care in India during COVID-19 pandemic and national lockdown period: Guidelines for physicians. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):273-6.
https://doi.org/10.1016/j.dsx.2020.04.001 [https://doi.org/10.1016/j.dsx.2020.05.010] [PMID]
15. Seyed Fatemi N, Modanloo M, et al. Design and Psychometrics of Treatment Adherence Questionnaire in Patients with Chronic Illness: A Combined Study. Koomesh. 2017;20(2):179-91. [https://brieflands.com/articles/koomesh-152948]
16. Coskun S, Bagcivan G. Associated factors with treatment adherence of patients diagnosed with chronic disease: Relationship with health literacy. Applied Nursing Research. 2021;57:151368. [https://doi.org/10.1016/j.apnr.2020.151368] [PMID]
17. Roka T, Ghimire M. Medication adherence among hypertensive patients attending a tertiary care hospital in Nepal. Journal of Nepal Health Research Council. 2019;17(4):521-7. [https://doi.org/10.33314/jnhrc.v17i4.2337] [PMID]
18. Pérez-Jover V, Mira JJ, Carratala-Munuera C, Gil-Guillen VF, Basora J, López-Pineda A, et al. Inappropriate use of medication by elderly, polymedicated, or multipathological patients with chronic diseases. International Journal of Environmental Research and Public Health. 2018;15(2):310. [https://doi.org/10.3390/ijerph15020310] [PMID]
19. Tavakoli Z. Effect of mindfulness-based stress reduction intervention on distress problems and self-regulation in patients with type 2 diabetes. Iranian Journal of Nursing Research. 2018;13(2):41-9.
20. Pirmardvand Chegini B, Zahrakar K, Sanai Zaker B. Effects of a Rational Emotive Behavior Therapy-Based Education Program on Marital Stress in Couples Coping with Breast Cancer. Iranian Journal of Breast Diseases. 2019;11(4):28-38. Available from: [https://doi.org/10.30699/acadpub.ijbd.11.04.28]
21. Baum A. Stress, intrusive imagery, and chronic distress. Health Psychology. 1990;9(6):653-75. [https://doi.org/10.1037/0278-6133.9.6.653] [PMID]
22. Ghezeljeh TN, Kohandany M, Oskouei FH, Malek M. The effect of progressive muscle relaxation on glycated hemoglobin and health-related quality of life in patients with type 2 diabetes mellitus. Applied Nursing Research. 2017;33:142-8. [https://doi.org/10.1016/j.apnr.2016.11.008] [PMID]
23. Morrison AE, Zaccardi F, Chatterjee S, Brady E, Doherty Y, Robertson N, et al. Self-compassion, metabolic control and health status in individuals with type 2 diabetes: A UK observational study. Experimental and Clinical Endocrinology and Diabetes. 2021;129(6):413-9. [https://doi.org/10.1055/a-0897-3772] [PMID]
24. Rahimi M, Jalali M, Nouri R, Rahimi M. The mediating role of resilience and diabetes distress in the relationship between depression and treatment adherence in Type 2 Diabetes among Iranian patients. Journal of Community Health Research. 2020;9(2):107-18. [https://doi.org/10.18502/jchr.v9i2.3404]
25. Gonzalez JS, Kane NS, Binko DH, Shapira A, Hoogendoorn CJ. Tangled up in blue: unraveling the links between emotional distress and treatment adherence in type 2 diabetes. Diabetes Care. 2016;39(12):2182-9. [https://doi.org/10.2337/dc16-1657] [PMID]
26. Eghbali M, Akbari M, Seify K, Fakhrolmobasheri M, Heidarpour M, Roohafza H, et al. Evaluation of Psychological Distress, Self-Care, and Medication Adherence in Association with Hypertension Control. International Journal of Hypertension. 2022;2022:7802792. [https://doi.org/10.1155/2022/7802792] [PMID]
27. Weissman J, Pratt LA, Miller EA, Parker JD. Serious psychological distress among adults: United States, 2009-2013. NCHS Data Brief. 2015;(203):1-8. [https://www.cdc.gov/nchs/data/databriefs/db203.pdf]
28. Tol A, Baghbanian A, Sharifirad G, Shojaeizadeh D, Eslami A, Alhani F, et al. Assessment of diabetic distress and disease-related factors in patients with type 2 diabetes in Isfahan: A way to tailor an effective intervention planning in Isfahan-Iran. Journal of Diabetes and Metabolic Disorders. 2012;11:20. [https://doi.org/10.1186/2251-6581-11-20] [PMID]
29. Ghanei Gheshlagh R, Ebadi A, Veisi Raygani A, Nourozi Tabrizi K, Dalvandi A, Mahmoodi H. Determining concurrent validity of the Morisky medication adherence scale in patients with type 2 diabetes. Iranian Journal of Rehabilitation Research in Nursing. 2015;1(3):24-32. [from: http://ijrn.ir/article-1-98-en.html]
30. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18(6):754-60. [https://doi.org/10.2337/diacare.18.6.754] [PMID]
31. Aliyari R. Short-form of the Iranian version of the problem areas in diabetes scale (IR-PAID-5): Validity and reliability. Iranian Journal of Endocrinology and Metabolism. 2016;18(1):21-7. [http://ijem.sbmu.ac.ir/article-1-2004-en.html]
32. Hermanns N, Caputo S, Dzida G, Khunti K, Meneghini LF, Snoek F. Screening, evaluation and management of depression in people with diabetes in primary care. Primary Care Diabetes. 2013;7(1):1-10. [https://doi.org/10.1016/j.pcd.2012.11.002] [PMID]
33. Dianati M, Taghadosi M. Medication adherence rate and related factors in patients with acute coronary syndrome after discharge from Shahid Beheshti Hospital in Kashan during 2017-2018. Feyz Medical Sciences Journal. 2019;23(2):201-8. [http://feyz.kaums.ac.ir/article-1-3737-en.html]
34. Gonzalez JS, Shreck E, Psaros C, Safren SA. Distress and type 2 diabetes-treatment adherence: A mediating role for perceived control. Health Psychology. 2015;34(5):505-13. [https://doi.org/10.1037/hea0000131] [PMID]
35. Kretchy IA, Koduah A, Ohene-Agyei T, Boima V, Appiah B. The association between diabetes-related distress and medication adherence in adult patients with type 2 diabetes mellitus: a cross-sectional study. Journal of Diabetes Research. 2020;2020:4760624. [https://doi.org/10.1155/2020/4760624] [PMID]
36. Fadaeaghdam N, Ameri M, Rezaei S, Mehravar F, Hoseini SS, Merhashemi B. Assessment of psychological distress and related factors in type 2 diabetic patients in diabetes center of Shahroud University of Medical Sciences in 2014. Journal of Clinical Nursing and Midwifery. 2017;5(4):13-21. [https://jcnm.skums.ac.ir/article-1-394-en.pdf]
37. Jafari M, Lotfizadeh M, Hashemi R. Investigating the relationship between stress, anxiety and depression with the quality of life of patients with multiple sclerosis. The Journal of Toloo-e-Behdasht. 2023;22(1):1-15. [https://doi.org/10.18502/tbj.v22i1.12776]
38. Ardouin S, Ball L, Burch E, Barton C, Sturgiss E, Williams LT. The prevalence of psychological distress in adults newly diagnosed with type 2 diabetes: Data from the Australian 3D case series study. Health Promotion Journal of Australia. 2024;35(2):534-41. [https://doi.org/10.1002/hpja.783] [PMID]
39. Shareinia H, Mamashli F, Mehranipoor B, Sadegh-Moghadam L, Daneshfar M. The Relationship between Spiritual Health and Hope by Adherence to the Medication Regimen in the Elderly with Type 2 Diabetes. Journal of Health System Research. 2023;19(2):95-102. Available from: [https://doi.org/10.48305/jhsr.v19i2.1491]
40. Mashrouteh M, Khanjani N, Gozashti MH. Evaluation of compliance with drug regimens in diabetic patients referred to the endocrinology clinic of Afzalipour Hospital, Kerman, Iran. Health and Development Journal. 2012;1(3):182-92. [https://jhad.kmu.ac.ir/article_91379_3fc31f244d4f034bb2fe9e7c4c298ebd.pdf]
41. Gholamaliei B, Karimi-Shahanjarini A, Roshanaei G, Rezapour-Shahkolaei F. Medication adherence and its related factors in patients with type II diabetes. Journal of Education and Community Health. 2016;2(4):3-12. [https://doi.org/10.21859/jech-02042]
42. Firooz M, Hosseini SJ, Mazlom SR, Hasan Zadeh F, Kimiyaee SA. Self-care of the patient with diabetes type II. Journal of Sabzevar University of Medical Sciences. 2016;22(6):1018-25. Available from: [https://jsums.medsab.ac.ir/article_786_en.html]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |